Moderna

2 Healthcare AI stocks to buy on the dip The Motley Fool05:41
Alnylam widens vaccine IP litigation against Pfizer, Moderna Law36019:33
Moderna sets up shop in China as fears of a 2nd wave rise NTD News14:11
Moderna Sets Up Shop in China Amid Fears of a 65 Million Per Week Infection Wave The Epoch Times20:32
Moderna 2020 rolls out new proximity store concept Checkout Magazine06:55
7 Undervalued biotech stocks MorningStar.com15:42
Moderna: Don't Try To Catch The Falling Knives Seeking Alpha15:23

Latest News

In the last 4 hours

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring? The Motley Fool08:09

In the last 6 hours

Academia Sinica, Moderna to cooperate on mRNA research Focus Taiwan06:34

In the last 8 hours

Taiwan’s Academia Sinica signs mRNA agreement with Moderna Taiwan News04:43

Yesterday

Moderna Buys GMP Plant in Marlborough for $91M Banker & Tradesman, Massachusetts11:46 31-May-23

Asian biosciences industry shines with multiple innovations BioSpectrum Asia10:08 31-May-23

2 Healthcare AI Stocks to Buy on the Dip The Motley Fool05:41 31-May-23

In the last 7 days

Alnylam Widens Vaccine IP Litigation Against Pfizer, Moderna Law36019:33 30-May-23

Alnylam files new round of lawsuits against Moderna and Pfizer over Covid-19 vaccines ENDPOINTS15:55 30-May-23

The hunt is on for the telltale biomarker revealing precise degree of protection conferred by… Medical Xpress12:29 30-May-23

Healey-Driscoll Administration and Massachusetts Life Sciences Center Announce $24.4 Million Job Creation Incentives… Massachusetts State Government (Press Release)11:43 30-May-23

Companies won’t share COVID-19 shots, stalling future vaccine research Science Magazine11:41 30-May-23

Oxford Properties Completes US$91 Million Sale of Newly Constructed, 140,000 Square Foot Boston … PR Newswire (Press Release)11:05 30-May-23

Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet… FiercePharma10:58 30-May-23

If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have Today The Motley Fool07:07 30-May-23

Who’s saying what? Future of Work mentions in company filings of pharmaceutical industry… Pharmaceutical Technology11:28 29-May-23

After battling COVID, can mRNA vaccines fight cancer? PBS Online08:51 28-May-23

Moderna Sets Up Shop in China as Fears of a 2nd Wave Rise NTD News14:11 27-May-23

Moderna Sets Up Shop in China Amid Fears of a 65 Million Per Week Infection Wave The Epoch Times20:32 26-May-23

While Pfizer, BioNTech agree to cut COVID vaccine supply to Europe, Moderna sets up shop in… FiercePharma18:54 26-May-23

Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines Reuters17:00 26-May-23

mRNA Vaccines Protect Against COVID-19 Mortality, Contrary to Misleading Posts Annenberg Political Fact Check15:49 26-May-23

IBM Generative AI Being Explored by Moderna for mRNA Vaccines Futurum Research15:10 26-May-23

Moderna registers biotech firm in Shanghai TVP World08:55 26-May-23

Moderna says looking for opportunities in China after registering legal entity Channel NewsAsia06:07 26-May-23

Moderna looks for opportunities in China after registering legal entity Reuters06:00 26-May-23

Moderna registers biotech firm in Shanghai, local media reports Channel NewsAsia05:56 26-May-23

7 Undervalued Biotech Stocks MorningStar.com15:42 25-May-23

Financial Literacy for All Welcomes American Express, Dow Jones, and Moderna to its Mission of… Business Wire (Press Release)12:02 25-May-23

In the last month

Is Moderna Stock A Buy After Unexpectedly Turning A First-Quarter Profit? Investors Business Daily19:12 24-May-23

Moderna: Don't Try To Catch The Falling Knives Seeking Alpha15:23 24-May-23

Stocks making the biggest moves midday: Abercrombie & Fitch, Palo Alto Networks, Moderna and more CNBC13:12 24-May-23

Moderna lays out $322m for mRNA manufacturing plant in MA BioProcess Insider09:20 24-May-23

Stocks making the biggest moves premarket: Moderna, Kohl's, Intuit, Analog Devices & more CNBC08:20 24-May-23

Billionaire Professor Tim Springer Donates $210 Million To Biomedical Research Nonprofit Forbes08:07 24-May-23

With Moderna windfall, Harvard professor and integrins legend Tim Springer donates $210M to his Institute for Protein… ENDPOINTS06:37 24-May-23

Delo welcomes change of Moderna Galerija director STA02:53 24-May-23

MarketingRx roundup: Moderna, Pfizer, J&J top pharmas on innovation list; Bristol Myers taps IPG for media ENDPOINTS13:11 23-May-23

Pfizer, Moderna COVID vaccines associated with severe vaginal bleeding in women 45 and up: study Just The News12:52 23-May-23

Cleburne Railroaders season opens May 23 North Texas eNews, Texas11:35 23-May-23

Is Moderna Stock a Buy Now? The Motley Fool10:09 23-May-23

Globe-trotting Moderna is investing $322M in new manufacturing site close to home: report FiercePharma08:43 23-May-23

Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far FierceBiotech07:30 23-May-23

Pfizer, Moderna among many biopharma giants to post Q1 sales declines, as Novo Nordisk led… FiercePharma07:22 23-May-23

Moderna 2020 Rolls Out New Proximity Store Concept Checkout Magazine06:55 23-May-23

Change at the helm of Moderna Galerija museum STA06:03 23-May-23

3 Stocks You'll Be Glad You Bought at These Prices The Motley Fool05:34 23-May-23

New Studies Find Covid Vaccines Are Safe For Kids: Here Are The Different Types Of Vaccines—And How They Work Forbes16:18 22-May-23

Here’s what Pfizer and Moderna say is next for their Covid vaccines CNBC12:26 22-May-23

Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy Zacks12:06 22-May-23

Moderna forges ahead with mRNA therapy after positive early clinical data Biopharma Reporter09:54 22-May-23

Moderna reports interim data of mRNA therapy for propionic acidemia Clinical Trials Arena05:32 22-May-23

Over $2bn wasted on unused Covid vaccines... as 13m Johnson & Johnson shots discarded Mail Online07:32 20-May-23

Moderna to purchase and invest more than $320M in MA biomanufacturing site ENDPOINTS14:36 19-May-23

Moderna, Medicines Company vets lead Comanche Biopharma toward preeclampsia trial ENDPOINTS11:12 19-May-23

Moderna touts first look at mRNA protein replacement for rare metabolic disease ENDPOINTS11:02 19-May-23

Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early… FierceBiotech10:36 19-May-23

Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented… BioSpace07:24 19-May-23

Johnson & Johnson COVID vaccines have 'expired'; CDC orders their disposal, says those who took them still need another … The Blaze11:44 18-May-23

Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69% The Motley Fool10:11 18-May-23

3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio The Motley Fool05:36 18-May-23

Studio Moderna sells brands to privatisation tycoon Horvat STA05:13 18-May-23

Moderna says 'moving at speed' to open PH facility by third quarter 2023 ABS-CBNnews.com23:00 17-May-23

Posts mislead on Covid vaccine efficacy study AFP Fact Check14:49 17-May-23

Vaccine to fight cancer shows promise using mRNA technology Twin Cities Pioneer Press14:28 17-May-23

Ready to Buy the Dip? This Biotech Stock Is a Smart Buy The Motley Fool08:04 17-May-23

Moderna hits back at Alnylam's 'baseless' patent infringement claims FiercePharma17:38 16-May-23

Could Latecomer Moderna Match Big Pharma Rivals in RSV? The Motley Fool14:04 16-May-23

Carter Jonas buoyed by MITC approval Insider Media02:58 16-May-23

Moderna goes after Alnylam, filing counterclaims in Spikevax patent suit ENDPOINTS15:11 15-May-23

REPORT: COVID Vaccines Are Causing SEVERE Neurological Complications Including Bell’s Palsy and … The National Pulse11:07 15-May-23

Harvard Professor Wrongly Belittles MRNA Covid Vaccine R&D In Congressional Testimony Forbes08:11 15-May-23

Moderna, Inc. – Consensus ‘buy’ rating and 55.7% Upside Potential DirectorsTalk Interviews07:31 15-May-23

The Vaccine Problem The Walrus06:31 15-May-23

Is It Too Late to Buy Moderna Stock? The Motley Fool05:41 15-May-23

Covid-19 vaccines cause myocarditis in youngsters, says study The Rio Times07:16 13-May-23

Moderna Fires Back At Rival's 'Baseless' Vaccine Patent Row Law36018:44 12-May-23

New Moderna hub will create next generation of vaccines Oxford Mail15:11 12-May-23

Moderna beats Pfizer among two-dose COVID vaccine recipients aged 60 and over, study shows Medical Xpress11:36 12-May-23

Updated Moderna booster shots available for young children starting May 16 Focus Taiwan11:35 12-May-23

Planning Consent for Moderna’s Innovation and Technology Centre (MITC) at Harwell Science and… Building Design & Construction Magazine05:38 12-May-23

3 Healthcare Stocks to Buy and Hold for the Next 10 Years The Motley Fool14:09 11-May-23

The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer The Motley Fool10:24 11-May-23

Covid-19: Sinovac vaccine to be sold in Hong Kong, as Moderna approved for local use Hong Kong Free Press06:38 11-May-23

World Premiere of Immersive Experience La Lucha Begins May 11 at La Jolla Playhouse Playbill00:09 11-May-23

Does Your Vaccine Type Matter in the Battle Against COVID? UC San Francisco14:55 10-May-23

Discovering Moderna’s new landscape for vaccines in Europe EurActiv.com01:31 10-May-23

Moderna says bivalent Covid vaccine approved for Hong Kong use South China Morning Post01:16 10-May-23

Coronavirus Hong Kong: US drug maker Moderna says bivalent Covid vaccine approved for local use, marking second such… South China Morning Post01:11 10-May-23

UCSF Researchers Study Degrees of COVID-19 Vaccine Protection NBC Bay Area, California20:13 9-May-23

Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite Center for Infectious Disease Research and Policy15:01 9-May-23

What to Know About the New COVID Booster Recommendations CNET13:46 9-May-23

UK health regulator authorizes Moderna COVID vaccine for infants as young as 6 months Anadolu Agency11:53 9-May-23

Antibody response varies for Big Pharma COVID vaccines European Pharmaceutical Review09:40 9-May-23

Moderna COVID-19 vaccine (Spikevax) authorised for use in infants and children aged 6 months to 5 years GOV.UK (Press Release)09:21 9-May-23

Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market The Motley Fool09:18 9-May-23

Factbox: GSK beats Pfizer, other rivals to win RSV vaccine race Reuters02:49 8-May-23

Is Moderna a Value Stock to Buy Right Now? The Motley Fool15:22 7-May-23

Chinese court data; Via Licensing buys MPEG; Moderna liability struggles; Cisco WIN++ programme; Qualcomm and… IAM07:28 7-May-23

[SUNDAY WATCH PARTY] EXCLUSIVE: Jessica Sutta, Former Pussycat Dolls Member: ‘I Was Severely Injured by the Moderna… The Epoch Times14:15 6-May-23

Is Moderna Building a Respiratory Vaccine Empire? The Motley Fool05:38 6-May-23

Moderna Museet Malmö opens 'Lotte Laserstein: A Divided Life' ArtDaily21:23 5-May-23

Moderna rakes in surprise profits ahead of 400% vaccine price hike Ars Technica12:37 5-May-23

US bosses enjoyed big pay rises in 2022 despite falling stock market The Irish Times10:17 5-May-23

Moderna expects updated COVID-19 vaccine to cost $110-$130 HealthLeaders09:47 5-May-23

STAT Plus: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts … STAT08:59 5-May-23

MODERNA and NOVOCOL PHARMA announce fill-finish Agreement for Canadian-made MRNA Vaccines NS Packaging08:45 5-May-23

Novocol signs fill-finish deal for Moderna’s mRNA respiratory vaccines Packaging Gateway05:46 5-May-23

Ticker: Study finds casino had ‘limited impact’ on crime; Moderna tops 1Q forecasts Boston Herald17:36 4-May-23

Covid-19: Pharma companies must make structural changes to ensure world can withstand future pandemics Amnesty International (Press Release)16:21 4-May-23

'Can You Defend It?': CNBC Host Grills Moderna CEO On ‘Ridiculous’ Pay The Daily Caller16:18 4-May-23

Moderna (MRNA) Q1 2023 Earnings Call Transcript Nasdaq15:50 4-May-23

Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2% Zacks14:30 4-May-23

Ontario Announces $4M Investment Towards mRNA Vaccine Production in Province The Epoch Times14:19 4-May-23

Moderna Stock Pops on Surprise Earnings Beat Kiplinger.com14:13 4-May-23

Doug Ford gives Moderna $4M to boost vaccine manufacturing in Ontario Toronto Star12:57 4-May-23

view more headlines

1 Jun 08:09

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

NewsNow brings you the latest news from the world’s most trusted sources on Moderna, a clinical-stage biotechnology company that focuses on developing therapeutics and vaccines based on messenger RNA (mRNA). NewsNow aims to be the world’s most accurate and comprehensive Moderna news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as Moderna news might appear - please feel free to contact us regarding any persistent issues.

Moderna

Latest News

About our Moderna news

Business Top Stories